newsfilter
← Latest News
Business Wire·

Health Canada Approves Ipsen's Sohonos™ (palovarotene capsules) as the First Approved Treatment for Fibrodysplasia Ossificans Progressiva

Regulatory News: Ipsen ((Euronext: IPN, OTC:IPSEY) today announced the Health Canada approval of Sohonos (palovarotene capsules), an oral selective retinoic-acid receptor gamma (RARγ) agonist indicated to reduce the formation of heterotopic ossifica